Nostrilla
- Product NDC
- 63736-730
- 11-digit product format
- 637360730
- Labeler code
- 63736
- Product ID
- 63736-730_5ab00067-efa6-fc48-e063-6294a90a6499
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Oxymetazoline Hydrochloride
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Labeler
- Insight Pharmaceuticals LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2009-06-08
- Substance
- OXYMETAZOLINE HYDROCHLORIDE
- Active strength
- .05 mg/100mL
- Pharmacologic classes
- Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63736-730 | 63736-730-02 | D | Discontinued by firm | 2026-10-23 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nostrilla
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OXYMETAZOLINE HYDROCHLORIDE | .05 mg/100mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| K89MJ0S5VY | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 86217847-8e2b-48cc-b289-4987fd3aa7c3 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 726062af-1135-4707-a1d7-57256991bbf9 | Product name | 2 | 20250226 |
| e67be450-f8e4-4bc1-88bd-1259d379f55f | Product name | 1 | 20210127 |
| c53f3286-4062-4cf5-8355-399519c639a6 | Product name | 1 | 20170424 |
| a993dfc5-f219-4460-bde6-30dd724d9ef0 | Product name | 1 | 20160818 |
| 19c71a3d-ed9c-166b-a7e5-38c250c35631 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 63736-730-01 | 2020-04-10 | Nostrilla |
| 63736-730-01 | 2020-04-10 | Nostrilla |
| 63736-730-02 | 2020-04-10 | Nostrilla |
| 63736-730-02 | 2020-04-10 | Nostrilla |
| 63736-730-01 | 2020-01-31 | Nostrilla |
| 63736-730-01 | 2020-01-31 | Nostrilla |
| 63736-730-02 | 2020-01-31 | Nostrilla |
| 63736-730-02 | 2020-01-31 | Nostrilla |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63736-730-01 | Nostrilla | 1 in 1 CARTON | SPRAY, METERED | 1 | 7 | |
| 63736-730-01 | Nostrilla | 15 mL in 1 BOTTLE, SPRAY | SPRAY, METERED | 15 | 7 | |
| 63736-730-02 | Nostrilla | 22.5 mL in 1 BOTTLE, SPRAY | SPRAY, METERED | 22.5 | 7 | |
| 63736-730-02 | Nostrilla | 1 in 1 CARTON | SPRAY, METERED | 1 | 7 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Oxymetazoline Hydrochloride | ACTIVE INGREDIENT | K89MJ0S5VY | NOSTRILLA (OXYMETAZOLINE HYDROCHLORIDE) SPRAY, METERED [INSIGHT PHARMACEUTICALS] | 2 | |
| Oxymetazoline | ACTIVE MOIETY | 8VLN5B44ZY | NOSTRILLA (OXYMETAZOLINE HYDROCHLORIDE) SPRAY, METERED [INSIGHT PHARMACEUTICALS] | 2 | |
| benzalkonium chloride | INACTIVE INGREDIENT | F5UM2KM3W7 | NOSTRILLA (OXYMETAZOLINE HYDROCHLORIDE) SPRAY, METERED [INSIGHT PHARMACEUTICALS] | 2 | |
| glycine | INACTIVE INGREDIENT | TE7660XO1C | NOSTRILLA (OXYMETAZOLINE HYDROCHLORIDE) SPRAY, METERED [INSIGHT PHARMACEUTICALS] | 2 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | NOSTRILLA (OXYMETAZOLINE HYDROCHLORIDE) SPRAY, METERED [INSIGHT PHARMACEUTICALS] | 2 | |
| sorbitol | INACTIVE INGREDIENT | 506T60A25R | NOSTRILLA (OXYMETAZOLINE HYDROCHLORIDE) SPRAY, METERED [INSIGHT PHARMACEUTICALS] | 2 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | NOSTRILLA (OXYMETAZOLINE HYDROCHLORIDE) SPRAY, METERED [INSIGHT PHARMACEUTICALS] | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mucus Relief Immediate Release | GUAIFENESIN | Allegiant Health | 221d64a2-b8c7-435a-aae4-fb58fd38108f | 2019-03-26 | Warnings | M012 |
| Sleep Tabs For Nighttime use | DIPHENHYDRAMINE HCL TABLETS | Allegiant Health | 566e40b1-e9d7-44e4-b971-eef2b7cf0a7d | 2018-12-26 | Warnings | M012 |
| Allergy | CHLORPHENIRAMINE MALEATE | Allegiant Health | 4305ad50-d2a5-4d3e-9d92-cbf26e856a16 | 2018-12-26 | Warnings | M012 |
| Sleep Aid | DIPHENHYDRAMINE HCL 25 MG | Allegiant Health | dbbc535f-515a-4d9b-b799-34e60f5230bb | 2018-12-21 | Warnings | M012 |
| Allergy | DIPHENHYDRAMINE HCL | Allegiant Health | c2823bad-540f-4662-8dcc-58e9f0d94efb | 2018-11-07 | Warnings | M012 |
| Nasal Decongestant PE Maximum Strength Non-Drowsy | PHENYLEPHRINE 10 MG | Allegiant Health | 7aef00df-816a-4ea2-a2ad-beed66dd2fe4 | 2018-11-07 | Warnings | M012 |
| DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | a58bfb14-28f9-4425-a5a5-aaff4847c979 | 2018-03-14 | Warnings | M012 |
| Chlorpheniramine maleate 4mg | CHLORPHENIRAMINE MALEATE 4MG | Athlete's Needs, Inc. | 4d974959-25fc-4707-9b72-9afbf47b76f1 | 2017-11-14 | Warnings | M012 |
| Cold Medicine | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Selder, S.A. de C.V. | d2762d9c-e7e7-42b2-a26a-14b2aa0307cb | 2017-01-25 | Warnings | M012 |
| Allergy | CHLORPHENIRAMINE MALEATE | Marc Glassman, Inc. | 2051247f-ce64-4cf5-b449-9ca14c43ab86 | 2016-12-27 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1001058 | Nostrilla 12 Hour 0.05 % Nasal Spray | PSN | 86217847-8e2b-48cc-b289-4987fd3aa7c3 | 7 |
| 1000990 | oxymetazoline HCl 0.05 % Nasal Spray | PSN | 86217847-8e2b-48cc-b289-4987fd3aa7c3 | 7 |
| 1001058 | oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Nostrilla] | SBD | 86217847-8e2b-48cc-b289-4987fd3aa7c3 | 7 |
| 1000990 | oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray | SCD | 86217847-8e2b-48cc-b289-4987fd3aa7c3 | 7 |
| 1001058 | Nostrilla 0.05 % Nasal Spray | SY | 86217847-8e2b-48cc-b289-4987fd3aa7c3 | 7 |
| 1001058 | Nostrilla 0.5 MG/ML Nasal Spray | SY | 86217847-8e2b-48cc-b289-4987fd3aa7c3 | 7 |
| 1000990 | oxymetazoline hydrochloride 0.05 % Nasal Spray | SY | 86217847-8e2b-48cc-b289-4987fd3aa7c3 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 63736-730-01 | 63736073001 | 1 BOTTLE, SPRAY in 1 CARTON (63736-730-01) / 15 mL in 1 BOTTLE, SPRAY | 2009-06-08 | 0000-00-00 | No | No | Current |
| 63736-730-02 | 63736073002 | 1 BOTTLE, SPRAY in 1 CARTON (63736-730-02) > 22.5 mL in 1 BOTTLE, SPRAY | 2009-06-08 | 0000-00-00 | No | No | Current |